FAQ - MATERIAL TRANSFER AGREEMENTS
A Material Transfer Agreement (MTAs) is a contract that protects your intellectual property (IP) when you either provide or receive research materials to and from other institutions or corporate entities. Research materials include cell lines, cultures, bacteria, nucleotides, proteins, transgenic animals, pharmaceuticals, or chemicals. Each exchange of research material requires an MTA. For repeated exchanges of the same research material, standardized MTAs can help streamline the process. CoMotion’s Agreements Group can help you efficiently transfer research materials.
Research materials that require MTAs are cell lines, cultures, transgenic animals, and pharmaceuticals, among others.
MTAs are important because they protect UW intellectual property rights, limit UW liability, and fairly credit the developer of the materials.
The Agreements Group within the UW Center for Commercialization manages most MTAs for the UW. If the MTA is embedded in a Sponsored Research Agreement, or is linked to a clinical trial, then the Office of Sponsored Programs (OSP) may be responsible for the MTA. The UW Center for Commercialization and OSP are the only units of the University authorized to review and sign MTAs.
UW researchers should contact the UW CoMotion Agreements Group, either by phone (206-543-3970) or by email@example.com. If the MTA is embedded in a Sponsored Research Agreement, is linked to a clinical trial, or is for clinical use or clinical studies in humans, then the Office of Sponsored Programs (OSP) is responsible for the MTA. CoMotion and OSP are the only units of the UW authorized to review and sign MTAs.
UW School of Medicine maintains a strict policy regarding the transfer of human biological material—any material that comes from a person—to third parties. Find detailed instructions here.
Jeanette Ennis supports UW researchers pursuing grant money to commercialize their innovations, and helps CoMotion secure economic development grant opportunities. Ennis joined CoMotion in 2009 after more than 15 years of broad research experience as a scientist, entrepreneur, and manager. Her areas of expertise include pharmacology, biochemistry, molecular biology, tissue engineering, and medical devices. She has worked with a variety of start-up companies as project manager, grant writer, and intellectual property manager, and held senior research positions at Cornell University and the UW Department of Cardiothoracic Surgery. She earned a doctorate in medical and molecular pharmacology from the University of California, Los Angeles, where she trained with Louis Ignarro, Nobel Laureate in Physiology. She also holds a certificate in technical writing and editing from the UW Department of Human Centered Design & Engineering.